Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has provided an update.
Shuttle Pharmaceuticals Holdings, Inc. has appointed seasoned finance professional Timothy J. Lorber as their new Chief Financial Officer. Lorber, with over 40 years of experience, including a significant tenure at Legg Mason, will transition from a part-time to a full-time role by September 2024. His compensation includes a $227,000 annual salary, equity in the form of restricted stock units, and potential bonuses, aligning with his extensive background in finance, M&A, and SEC reporting. The company has also recognized the contributions of the outgoing CFO, Mr. Michael Vander Hoek, who will now focus fully on his role as Vice President, Regulatory.
Learn more about SHPH stock on TipRanks’ Stock Analysis page.
